Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) - Dataset (ID:20272)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule 1 | Small Molecule 2 | Small Mol 1 Concentration | Small Mol 2 Concentration | Small Mol Conc Unit | Time Point | Time Point Unit | Replicate | Total Number of Cells (Nuclei) | Number of Apoptotic Cells | Relative Viability | Mean Relative Viability | Apoptosis Fraction | Mean Apoptosis Fraction |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 2 | 726 | 696 | 0.0051 | 0.0054 | 0.9587 | 0.9547 |
COLO 858 | Vemurafenib | Defactinib | 0.100 | 3.160 | uM | 72 | hr | 3 | 1178 | 697 | 0.0571 | 0.0598 | 0.5917 | 0.6178 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 3 | 5271 | 697 | 0.7585 | 0.7398 | 0.1322 | 0.1305 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 3.160 | uM | 72 | hr | 3 | 3469 | 698 | 0.4595 | 0.4677 | 0.2012 | 0.1974 |
WM-115 | Vemurafenib | (+)-JQ1 | 3.160 | 1.000 | uM | 72 | hr | 2 | 1263 | 699 | 0.1730 | 0.1677 | 0.5534 | 0.5580 |
COLO 858 | Vemurafenib | (+)-JQ1 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1602 | 701 | 0.2735 | 0.2031 | 0.4376 | 0.4582 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 0.316 | uM | 72 | hr | 3 | 1101 | 702 | 0.0662 | 0.0722 | 0.6376 | 0.5757 |
COLO 858 | Vemurafenib | I-BET151 | 0.316 | 1.000 | uM | 72 | hr | 2 | 1178 | 702 | 0.1100 | 0.1085 | 0.5959 | 0.5981 |
COLO 858 | Vemurafenib | JNK-IN-8 | 0.000 | 1.000 | uM | 72 | hr | 2 | 5229 | 702 | 0.7507 | 0.7398 | 0.1343 | 0.1305 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.000 | uM | 72 | hr | 1 | 1706 | 704 | 0.1431 | 0.1375 | 0.4127 | 0.4603 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 1.000 | uM | 72 | hr | 1 | 4700 | 704 | 0.4744 | 0.5301 | 0.1498 | 0.1528 |
A-375 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 3 | 1148 | 705 | 0.0338 | 0.0484 | 0.6141 | 0.5323 |
COLO 858 | Vemurafenib | PF562271 | 1.000 | 0.000 | uM | 72 | hr | 3 | 1510 | 705 | 0.1452 | 0.1377 | 0.4669 | 0.4424 |
COLO 858 | Vemurafenib | Belinostat | 3.160 | 1.000 | uM | 72 | hr | 3 | 957 | 706 | 0.0576 | 0.0767 | 0.7377 | 0.7291 |
WM-115 | Vemurafenib | Dasatinib | 0.316 | 0.316 | uM | 72 | hr | 1 | 1897 | 707 | 0.2971 | 0.2711 | 0.3727 | 0.3806 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 2 | 1666 | 709 | 0.1136 | 0.1023 | 0.4256 | 0.4297 |
COLO 858 | Vemurafenib | Dasatinib | 0.100 | 0.316 | uM | 72 | hr | 2 | 1738 | 710 | 0.1469 | 0.1453 | 0.4085 | 0.3955 |
COLO 858 | Vemurafenib | Defactinib | 0.316 | 1.000 | uM | 72 | hr | 3 | 1514 | 710 | 0.0955 | 0.1083 | 0.4690 | 0.4526 |
COLO 858 | Vemurafenib | JNK-IN-8 | 1.000 | 0.316 | uM | 72 | hr | 1 | 1201 | 711 | 0.0813 | 0.0722 | 0.5920 | 0.5757 |
COLO 858 | Vemurafenib | Defactinib | 0.000 | 3.160 | uM | 72 | hr | 1 | 1609 | 714 | 0.1063 | 0.1023 | 0.4438 | 0.4297 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 0.316 | uM | 72 | hr | 3 | 759 | 718 | 0.0069 | 0.0093 | 0.9460 | 0.9244 |
COLO 858 | Vemurafenib | (+)-JQ1 | 3.160 | 0.000 | uM | 72 | hr | 1 | 972 | 720 | 0.0765 | 0.0787 | 0.7407 | 0.7868 |
COLO 858 | Vemurafenib | JNK-IN-8 | 3.160 | 3.160 | uM | 72 | hr | 2 | 759 | 722 | 0.0061 | 0.0089 | 0.9513 | 0.9423 |
COLO 858 | Vemurafenib | Dasatinib | 1.000 | 0.316 | uM | 72 | hr | 1 | 840 | 724 | 0.0166 | 0.0153 | 0.8619 | 0.8976 |
COLO 858 | Vemurafenib | Saracatinib | 3.160 | 3.160 | uM | 72 | hr | 3 | 752 | 724 | 0.0047 | 0.0054 | 0.9628 | 0.9547 |